Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AEM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Applied and Environmental Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AEM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Public Health Microbiology

Safety Assessment of the Oral Cavity Probiotic Streptococcus salivarius K12

Jeremy P. Burton, Philip A. Wescombe, Chris J. Moore, Chris N. Chilcott, John R. Tagg
Jeremy P. Burton
1BLIS Technologies Ltd.
2Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jeremy.burton@blis.co.nz
Philip A. Wescombe
1BLIS Technologies Ltd.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris J. Moore
1BLIS Technologies Ltd.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris N. Chilcott
1BLIS Technologies Ltd.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John R. Tagg
1BLIS Technologies Ltd.
2Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AEM.72.4.3050-3053.2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Streptococcus salivarius K12 (even-numbered lanes) and S. pyogenes SF370 (odd-numbered lanes) amplification products resulting from PCR using specific primers for the sagA (lanes 2 and 3), scpA (lanes 5 and 6), smez-2 (lanes 8 and 9), speB (lanes 11 and 12), and emm (lanes 14 and 15) genes. Lanes 1 and 17, 1-kb marker (Gibco).

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Autoradiographs of Southern blots hybridized with amplicons of the different streptococcal virulence factors (given at the bottom). Lanes containing HindIII-digested DNA from S. pyogenes SF370 are labeled SF370. Lanes containing HindIII-digested DNA from S. salivarius strain K12 are labeled K12.

Tables

  • Figures
  • TABLE 1.

    Antibiotic disk sensitivities of S. salivarius isolates

    Antibiotic (concn [μg])Inhibition zone size (mm) for:
    Strain K12 lineageHDToveR#6K30HAHBHCK26R
    K12- J89aK12- LabbK12- BN21c
    Penicillin (10)3434393429262626272728
    Amoxicillin (10)3532353528262926262827
    Ofloxacin (5)18d18d15d18d19d17d16d16d18d16d18d
    Tetracycline (30)2827262827272227282827
    Erythromycin (15)3030313028292628292727
    Gentamicin (10)15d14d14d15d15d16d14d12d12d12d14d
    Clindamycin (2)2926282928262629302825
    • ↵ a Original isolate.

    • ↵ b Routinely subcultured isolate.

    • ↵ c Isolate from commercial batch.

    • ↵ d Moderately resistant.

  • TABLE 2.

    API 20 Strep and API 50CH positive reactions for Streptococcus salivarius K12 cultures

    TestReaction of:
    K12-J89aK12-LabbK12-BN21c
    API 20 Strepd
        Acetoin production+++
        β-Glucosidase+++
        Alkaline phosphatase+++
        Leucine aminopeptidase+++
        d-Lactose+++
        d-Trehalose+++
        Inulin+++
        d-Raffinose+++
    API 50CH
        d-Galactose+++
        d-Glucose+++
        d-Fructose+++
        d-Mannose+++
        N-Acetylglucosamine+++
        Arbutine+++
        Salicin+++
        d-Cellobiose+++
        d-Maltose+++
        d-Lactose+++
        d-Saccharose+++
        d-Trehalose+++
        Inulin+++
        d-Raffinose+++
        d-Tagatose+++
    • ↵ a Original isolate.

    • ↵ b Routinely subcultured isolate.

    • ↵ c Isolate from commercial batch.

    • ↵ d The API 20 Strep code for all three isolates was 5060470.

  • TABLE 3.

    Primers used to amplify streptococcal virulence genes

    Virulence determinantGene designationPrimer namePrimer sequence (5′-3′)Amplicon size (bp)Reference
    Streptolysin S sagA sagA FwdATTGAGCTAGCCTTGTCCTTGT1,164This study
    sagB RevGTATTCCGCAAAATCTCTAACG
    C5a peptidase scpA scpA FwdCGGGTATCATGGGACTGTTGC1,259This study
    scpA RevTTGCCGATGTTGCGACTTC
    SMEZ-2 smez-2 smez-2 FwdGGACGAATATGCAGCCAATGA332This study
    smez-2 RevGTATGAAAAACCAGTCTACCAC
    SPE-B speB speB FwdTGACGCTAACGGTAAAGAAAACA819This study
    speB RevGCCGCCACCAGTACCAAGAGC
    M-protein emm M-all FwdTATTSGCTTAGAAAATTAA961 13
    M-all RevGCAAGTTCTTCAGCTTGTTT
  • TABLE 4.

    Counts of facultatively anaerobic bacteria and S. salivarius in saliva of individuals prior to and in the days following dosing with S. salivarius K12a

    Organism(s)Mean CFU/ml (SD) at the following time of sampling:Maximum CFU/ml detected in any single sample
    PredosingDay 3Day 7Day 14Day 28
    Facultatively anaerobic bacteria3.11e7 (2.4e7)3.09e7 (2.1e7)3.98e7 (2.3e7)3.93e7 (2.9e7)3.32e7 (2.1e7)1.1e8
    S. salivarius 1.54e7 (2.4e7)7.80e6 (1.3e7)1.33e7 (1.1e7)6.58e6 (5.9e6)7.2e6 (7.1e6)7.7e7
    • ↵ a Subjects included 4 males and 10 females; mean age, 19 years. P values for time point differences for counts of facultatively anaerobic bacteria and S. salivarius were not significant (>0.5 by nonparametric analysis of variance).

  • TABLE 5.

    Detection of specific microorganisms in saliva of individuals prior to and in the days following dosing with Streptococcus salivarius K12a

    Organism(s)No. of subjects in which the indicated class of microbe was detected/total no. of subjects at the following sampling time:Maximum CFU/ml detected in any single sample
    PredosingDay 3Day 7Day 14Day 28
    S. salivarius K12-like BLISc profile2/1413/1412/149/144/14NAd
    S. salivarius K12-like BLIS profile >50%2/147/147/143/141/14NA
    S. mutans b 9/1411/149/1411/149/136.3e5
    S. mutans >1e4 CFU/ml4/144/144/145/144/14NA
    S. mutans >1e5 CFU/ml2/142/141/141/141/14NA
    Lactobacilli6/145/144/147/142/142.8e5
    Candida 1/14NDe1/141/141/144.4e4
    Coliforms1/142/140/141/140/14140
    Pseudomonas 11/148/1410/149/145/14100
    Staphylococcus aureus 3/144/141/142/142/141,000
    • ↵ a Subjects included 4 males and 10 females; mean age, 19 years.

    • ↵ b P values for time point differences for S. mutans counts were not significant (>0.5 by nonparametric analysis of variance).

    • ↵ c BLIS, bacteriocin-like inhibitory substance.

    • ↵ d NA, not applicable.

    • ↵ e ND, not determined.

PreviousNext
Back to top
Download PDF
Citation Tools
Safety Assessment of the Oral Cavity Probiotic Streptococcus salivarius K12
Jeremy P. Burton, Philip A. Wescombe, Chris J. Moore, Chris N. Chilcott, John R. Tagg
Applied and Environmental Microbiology Apr 2006, 72 (4) 3050-3053; DOI: 10.1128/AEM.72.4.3050-3053.2006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Applied and Environmental Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Safety Assessment of the Oral Cavity Probiotic Streptococcus salivarius K12
(Your Name) has forwarded a page to you from Applied and Environmental Microbiology
(Your Name) thought you would be interested in this article in Applied and Environmental Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Safety Assessment of the Oral Cavity Probiotic Streptococcus salivarius K12
Jeremy P. Burton, Philip A. Wescombe, Chris J. Moore, Chris N. Chilcott, John R. Tagg
Applied and Environmental Microbiology Apr 2006, 72 (4) 3050-3053; DOI: 10.1128/AEM.72.4.3050-3053.2006
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Mouth
probiotics
Streptococcus

Related Articles

Cited By...

About

  • About AEM
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AppEnvMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

 

Print ISSN: 0099-2240; Online ISSN: 1098-5336